These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8152263)

  • 1. Potential strategies for circumventing myeloperoxidase-catalyzed degradation of vinca alkaloids.
    Schlaifer D; Cooper MR; Attal M; Rousseau A; Pris J; Laurent G; Myers CE
    Leukemia; 1994 Apr; 8(4):668-71. PubMed ID: 8152263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of vinca alkaloids with tubulin: a comparison of vinblastine, vincristine, and vinorelbine.
    Lobert S; Vulevic B; Correia JJ
    Biochemistry; 1996 May; 35(21):6806-14. PubMed ID: 8639632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vincristine degradation by serum from leukemic patients: role of myeloperoxidase.
    Schlaifer D; Duchayne E; Demur C; Alvinerie P; Muller C; Attal M; Cooper MR; Payen C; Monsarrat B; Myers CE; Pris J; Laurent G
    Leuk Lymphoma; 1996 Feb; 20(5-6):441-6. PubMed ID: 8833400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further elucidation of mechanism of resistance to vincristine in myeloid cells: role of hypochlorous acid in degradation of vincristine by myeloperoxidase.
    Ozgen U; Savaşan S; Stout M; Buck S; Ravindranath Y
    Leukemia; 2000 Jan; 14(1):47-51. PubMed ID: 10637476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical pharmacokinetics of vinorelbine (Navelbine).
    Wargin WA; Lucas VS
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):21-7. PubMed ID: 7973765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical effects of Navelbine on tubulin and associated proteins.
    Fellous A; Ohayon R; Vacassin T; Binet S; Lataste H; Krikorian A; Couzinier JP; Meininger V
    Semin Oncol; 1989 Apr; 16(2 Suppl 4):9-14. PubMed ID: 2496470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Energetics of vinca alkaloid interactions with tubulin isotypes: implications for drug efficacy and toxicity.
    Lobert S; Frankfurter A; Correia JJ
    Cell Motil Cytoskeleton; 1998; 39(2):107-21. PubMed ID: 9484953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degradation of vincristine by myeloperoxidase and hypochlorous acid in children with acute lymphoblastic leukemia.
    Ozgen U; Türköz Y; Stout M; Ozuğurlu F; Pelik F; Bulut Y; Aslan M; Ravindranath Y; Savaşan S
    Leuk Res; 2003 Dec; 27(12):1109-13. PubMed ID: 12921949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunofluorescence study of the action of navelbine, vincristine and vinblastine on mitotic and axonal microtubules.
    Binet S; Chaineau E; Fellous A; Lataste H; Krikorian A; Couzinier JP; Meininger V
    Int J Cancer; 1990 Aug; 46(2):262-6. PubMed ID: 2200754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposome-encapsulated vincristine, vinblastine and vinorelbine: a comparative study of drug loading and retention.
    Zhigaltsev IV; Maurer N; Akhong QF; Leone R; Leng E; Wang J; Semple SC; Cullis PR
    J Control Release; 2005 May; 104(1):103-11. PubMed ID: 15866338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense inhibition of myeloperoxidase increases the sensitivity of the HL-60 cell line to vincristine.
    Schlaifer D; Meyer K; Muller C; Attal M; Smith MT; Tamaki S; Weimels J; Pris J; Jaffrézou JP; Laurent G
    Leukemia; 1994 Feb; 8(2):289-91. PubMed ID: 7905941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human hepatic uptake of two vinca alkaloids: navelbine and vincristine.
    Rahmani-Jourdheuil D; Coloma F; Placidi M; Rahmani R
    J Pharm Sci; 1994 Apr; 83(4):468-71. PubMed ID: 8046598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunoassay and preliminary pharmacokinetic studies in rats of 5'-noranhydrovinblastine (navelbine).
    Rahmani R; Martin M; Barbet J; Cano JP
    Cancer Res; 1984 Dec; 44(12 Pt 1):5609-13. PubMed ID: 6498821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the tumor disposition of vinca alkaloids by PSC 833 in vitro and in vivo.
    Song S; Suzuki H; Terasaki T; Lemaire M; Sugiyama Y
    J Pharmacol Exp Ther; 1998 Dec; 287(3):963-8. PubMed ID: 9864280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidations of vincristine catalyzed by peroxidase and ceruloplasmin.
    Ahn SH; Duffel MW; Rosazza JP
    J Nat Prod; 1997 Nov; 60(11):1125-9. PubMed ID: 9392881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative pharmacokinetics of antitumor Vinca alkaloids: intravenous bolus injections of navelbine and related alkaloids to cancer patients and rats.
    Rahmani R; Guéritte F; Martin M; Just S; Cano JP; Barbet J
    Cancer Chemother Pharmacol; 1986; 16(3):223-8. PubMed ID: 3698163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloperoxidase and horseradish peroxidase catalyze tyrosine nitration in proteins from nitrite and hydrogen peroxide.
    Sampson JB; Ye Y; Rosen H; Beckman JS
    Arch Biochem Biophys; 1998 Aug; 356(2):207-13. PubMed ID: 9705211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing the Mechanisms Underlying the Transport of the Vinca Alkaloids by P-glycoprotein.
    Mensah GAK; Schaefer KG; Roberts AG; King GM; Bartlett MG
    J Pharm Sci; 2024 Jul; 113(7):1960-1974. PubMed ID: 38527618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake of Vinca alkaloids into mammalian nerve and its subcellular components.
    Iqbal Z; Ochs S
    J Neurochem; 1980 Jan; 34(1):59-68. PubMed ID: 6161213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vinca alkaloid skin toxicity: antidote and drug disposition studies in the mouse.
    Dorr RT; Alberts DS
    J Natl Cancer Inst; 1985 Jan; 74(1):113-20. PubMed ID: 3855472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.